Thursday - October 16, 2025
Following tireless advocacy, Carter celebrates FDA approval for Barth syndrome treatment
September 19, 2025
WASHINGTON, Sept. 19 -- Rep. Earl L. Carter, R-Georgia, issued the following news release:

* * *

Following tireless advocacy, Carter celebrates FDA approval for Barth syndrome treatment

*

WASHINGTON, D.C. - Rep. Earl L. "Buddy" Carter (R-GA) today celebrated the Food and Drug Administration's (FDA) announcement that it has granted an accelerated approval for Stealth Biotherapeutics' Barth syndrome treatment, Forzinity (elami . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products